Filed: 8/14/2024ACC: 0000905148-24-002220
📋 What this filing means
VENBIO PARTNERS LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $231.52M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$231.52M
Total AUM (reported)
24.14M
Total Shares
Allocation by class
COM$231.52M100.0%
Portfolio Concentration
Top 3$176.72M76.3%
4–10$54.80M23.7%
Top 3 weight
76.3%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 24.14M
Sole
Full voting authority
24.14M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
PHARVARIS N V
SOLEShares4.29M
TypeSH
Market value$80.64M
34.83%
Sole
4.29M
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
SOLEShares9.70M
TypeSH
Market value$58.49M
25.26%
Sole
9.70M
Shared
0.00
None
0.00
ALUMIS INC
SOLEShares2.83M
TypeSH
Market value$37.59M
16.23%
Sole
2.83M
Shared
0.00
None
0.00
HARMONY BIOSCIENCES HLDGS IN
SOLEShares1.04M
TypeSH
Market value$31.24M
13.49%
Sole
1.04M
Shared
0.00
None
0.00
ACELYRIN INC
SOLEShares3.85M
TypeSH
Market value$16.99M
7.34%
Sole
3.85M
Shared
0.00
None
0.00
ELEVATION ONCOLOGY INC
SOLEShares2.43M
TypeSH
Market value$6.57M
2.84%
Sole
2.43M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
PHARVARIS N VSOLE | COM | 4.29M | SH | $80.64M 34.83% | 4.29M | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCSOLE | COM | 9.70M | SH | $58.49M 25.26% | 9.70M | 0.00 | 0.00 |
ALUMIS INCSOLE | COM | 2.83M | SH | $37.59M 16.23% | 2.83M | 0.00 | 0.00 |
HARMONY BIOSCIENCES HLDGS INSOLE | COM | 1.04M | SH | $31.24M 13.49% | 1.04M | 0.00 | 0.00 |
ACELYRIN INCSOLE | COM | 3.85M | SH | $16.99M 7.34% | 3.85M | 0.00 | 0.00 |
ELEVATION ONCOLOGY INCSOLE | COM | 2.43M | SH | $6.57M 2.84% | 2.43M | 0.00 | 0.00 |